Biotechnology industry: future needs and trends. Roland Wohlgemuth

Transcription

1 Biotechnology industry: future needs and trends Roland Wohlgemuth

2 Overview Introduction Innovation Outlook and Opportunities

3 Introduction

4 European Federation of Biotechnology (EFB)

5 European Federation of Biotechnology (EFB) History Established by European scientists in 1978, the European Federation of Biotechnology (EFB) is working to promote biotechnology throughout Europe and beyond.

6 European Federation of Biotechnology (EFB) Mission The mission of EFB is to promote the safe, sustainable and beneficial use of the life sciences, to promote research and innovation at the cutting edge of biotechnology, to provide a forum for interdisciplinary and international cooperation, to improve scientific education and to facilitate an informed dialogue between scientists and the public.

7 European Federation of Biotechnology (EFB) Members and Organization With 108 Institutional members from across Europe and personal members, the EFB has 14 Regional Branch Offices in Europe. The EFB Central Office (ECO) is located in Barcelona, Spain. Membership administration, organization of Executive Board meetings and General Assemblies, website management and organization of the European Congresses on Biotechnology are some of the main responsibilities of ECO.

8 The European Association for Bioindustries History and Organisation The European Association for Bioindustries (EuropaBio) was created in 1996 to provide a voice for the biotech industry in Europe. The three main segments of biotechnology are represented through sectoral councils: Healthcare (Red Biotech), Industrial (White Biotech) and Agri-Food (Green Biotech).The corporate members are involved in human and animal healthcare, diagnostics, bioinformatics, chemicals, crop protection, agriculture, food and environmental products and services. The board of management is made up of representatives of member companies and is supported by the secretariat.

9 The European Association for Bioindustries Members EuropaBio has 62 corporate and 7 associate members operating worldwide, 2 Bioregions and 19 national biotechnology associations representing some 1800 small and medium sized enterprises.

10 Creating Value for the Customer, Coworker/Co-owner and Citizen Goal: Focus on optimizing customer satisfaction while setting minimum boundary conditions for the other variables Tools: Raw Materials - Science/Technology - Product Development - Manufacturing - Service - Supply Chain - Sales/Marketing

11 Creating Value for the Customer, Coworker/Co-owner and Citizen Sustainable Value Creation well-balanced and anchored in Science-Industry-Society Concept of a more sustainable use of limited resources as a driving force for the rapid development of sustainable bioeconomies in US - EU Value creation by the conversion of abundant and inexpensive raw material into higher value products

12 Innovation

13 Global Challenges R.Wohlgemuth, New Biotechnology 25, (2009)

14 Ressource Efficiency Product Intermediate Intermediate Raw Material R.Wohlgemuth, Chem. Biochem. Eng. Q. 25 (1) (2011)

15 Ressource Efficiency Waste Minimization by Molecular Economy High Step Economy by Reducing the Number of Steps and Direct Transformations instead of Protection-Transformation-Deprotection Sequences Selective Transformations with High Atom Economy Redox Economy Product Isolations & Purifications with Minimization of Auxiliary Reagents and Solvents Waste as Raw Material for New Processes R.Wohlgemuth, Chem. Biochem. Eng. Q. 25 (1) (2011)

16 Atmospheric Carbon dioxide - Past and Present P.N.Pearson, M.R.Palmer, Nature 406, (2000) C.D.Keeling et al, Nature 375, (1995)

17 Science/Technology Precompetitive Fundamental Research on Novel Industrial Biotechnology Platform Technologies, e.g. Carbondioxide-Utilization Reactions with a Time Horizon of 10 Years and improving Ressource Efficiency Capacity Building for the molecular sciences of synthesis (chemistry and biotechnology), bioproduction and engineering of new reagents, drugs and materials towards Personalized Medicine Precompetitive Fundamental Research on Novel Bioanalytical Platform Technologies

18 Science/Technology Going beyond the present Functional Universe of Enzymes R.Wohlgemuth, New Biotechnol. 25, (2009)

19 Science/Technology Guidelines for Reporting of Biocatalytic Reactions Global standards Functional Database L.Gardossi, P.Poulsen, A.Ballesteros, K.Hult, V.Svedas, D.Vasic-Racki, G.Carrea, A.Magnusson, A.Schmid, R.Wohlgemuth, P.Halling, Trends in Biotechnol. 28, (2010).

20 Science/Technology Value creation by integrated bioprocesses: Molecular and engineering aspects of the overall bioprocess are interconnected R.Wohlgemuth, Chem. Biochem. Eng. Q. 25 (1) (2011)

21 Outlook and Opportunities

22 Sustainable Bioeconomy With the Common Understanding and Agreement that this is the Way Forward, bioeconomy - subfields of mutual interest to the US and EU can be defined Establishing Information Exchange US- EU in these bioeconomy-subfields US-EU Exchange Program of Scientists in these defined bioeconomy subfields

23 Sustainable Bioeconomy The Time of Action is now and extensive efforts are needed for the transition of the US- and EU-economies to a sustainable bioeconomy Building New Value Creation Chains Focus on Generally Recognized As Safe Biological Cells

24 Sustainable Bioeconomy Moving towards the Whole Molecular System of Cells R.Wohlgemuth, Biotechnol.J. 9, (2009).

25 Thank You for Your Attention! Roland Wohlgemuth